| 000 | 01633nam a2200421Ia 4500 | ||
|---|---|---|---|
| 001 | 336358 | ||
| 003 | BD | ||
| 005 | 20161013074818.0 | ||
| 006 | m o d f | ||
| 007 | cr bn||||m|||| | ||
| 008 | 160404s2016 dcu ob f000 0 eng c | ||
| 040 |
_aPUCPR _beng _erda _epn _cGPO _dGPO |
||
| 041 | _aspa | ||
| 042 | _apcc | ||
| 043 | _an-us--- | ||
| 049 | _aBDDF | ||
| 050 | 1 | 4 |
_aKF26 _b.L27 2013 |
| 074 | _a1043-A | ||
| 086 | 0 | _aY 4.L 11/4:S.HRG.113-756 | |
| 099 | _aY 4.L 11/4:S.HRG.113-756 | ||
| 110 | 1 |
_aUnited States _bCongress. _bSenate. _bCommittee on Health, Education, Labor, and Pensions. _eauthor. _9182913 |
|
| 245 | 1 | 0 |
_aPharmaceutical compounding _bproposed legislative solution : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, first session ... May 9, 2013. |
| 264 | 1 |
_aWashington _bU.S. Government Publishing Office _c2016. |
|
| 300 |
_aiii, 60 pages ; _c24 cm. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_aunmediated _bn _2rdamedia |
||
| 338 |
_avolume _bnc _2rdacarrier |
||
| 490 | 1 |
_aS. hrg. _v113-756 |
|
| 500 | _aCRDP Project record. | ||
| 504 | _aIncludes bibliographical references. | ||
| 650 | 0 |
_aDrugs _xDosage forms _zUnited States. _988821 _2Local |
|
| 650 | 0 |
_aDrug adulteration _xLaw and legislation _zUnited States. _988787 _2Local |
|
| 655 | 7 |
_aLegislative hearings _2lcgft _9124577 _2Local |
|
| 810 | 1 |
_aUnited States. _bCongress. _bSenate. _tS. hrg. _v113-756. |
|
| 856 | 4 | 1 |
_3PDF version _uhttp://purl.fdlp.gov/GPO/gpo66753 |
| 856 | 4 | 1 |
_3Text version _uhttp://purl.fdlp.gov/GPO/gpo66754 |
| 942 |
_2sudocs _c15 |
||
| 999 |
_c252850 _d252850 |
||